LifeMD (LFMD) Non Operating Interest Expenses (2012 - 2025)

LifeMD (LFMD) has reported Non Operating Interest Expenses for 14 consecutive years, with -$190791.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Non Operating Interest Expenses fell 131.4% year-over-year to -$190791.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 37.44% YoY), and the FY2025 full-year result was $1.4 million, down 37.44% from the prior year.
• Non Operating Interest Expenses declined to -$190791.0 in Q4 2025 per LFMD's latest filing, from $262456.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.8 million in Q3 2021 and bottomed at -$190791.0 in Q4 2025.
• Historically, Non Operating Interest Expenses has averaged $521431.0 across 5 years, with a median of $545032.5 in 2024.
• The sharpest annual moves came in 2023 and 2025: Non Operating Interest Expenses jumped 652.95% in 2023, then tumbled 131.4% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $153566.0 in 2021, then surged by 449.3% to $843541.0 in 2022, then decreased by 26.18% to $622685.0 in 2023, then decreased by 2.41% to $607662.0 in 2024, then tumbled by 131.4% to -$190791.0 in 2025.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$190791.0, $262456.0, and $663027.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.